Zizhu gets China rights to Uni-Bio's eye drug

Uni-Bio Science Group Ltd. (HKSE:690) said it granted exclusive commercialization rights in China to ophthalmology treatment GeneSoft to the China Resources Zizhu Pharmaceutical Co. Ltd. subsidiary of China Resource Pharmaceuticals Group (Beijing, China). Zizhu will have rights to GeneSoft for five years, with an option to renew for an additional five years. ...